Clinical Trial Update: Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating felbamate for treatment-resistant bipolar depression has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• FELBAMATE (felbamate)

Snippet

Sponsor: National Institute of Mental Health (NIMH) | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED